Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy

Cellular Physiology and Biochemistry

Volumn 28, Issue 1, 2011, Pages 125-136

  Pfister, Frederick ^a   Riedl, Eva ^a   Wang, Qian ^a   Vom Hagen, Franziska ^a   Deinzer, Martina ^b   Harmsen, Martin C ^c   Molema, Grietje ^c   Yard, Benito ^a   Feng, Yuxi ^a   Hammes, Hans Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

AGE; Ang 2; Carnosine; Diabetic retinopathy; Hsp 27; Neuroglia; Pericytes; ROS; Vasoregression

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOPOIETIN 2; CARNOSINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; HEAT SHOCK PROTEIN 27; HEME OXYGENASE 1; HEMOGLOBIN A1C; HEXOSAMINE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL INJURY; BODY WEIGHT; CATARACTOGENESIS; CELL ACTIVATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; GLIA CELL; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MALE; MORPHOMETRICS; NERVE INJURY; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALIA; RATTUS NORVEGICUS;

EID: 80051998391     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000331721     Document Type: Article

References (55)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The wisconsin epidemiologic study of diabetic retinopathy. Iii. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-532. (Pubitemid 14127839)
2. Hammes HP: Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 2005;37 Suppl 1:39-43.
3. Barber AJ: A new view of diabetic retinopathy: A neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:283-290. (Pubitemid 36351495)
4. Cogan DG, Toussaint D, Kuwabara T: Retinal vascular patterns. Iv. Diabetic retinopathy. Arch Ophthalmol 1961;66:366-378.
5. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820. (Pubitemid 34000785)
6. Hammes HP, Ali SS, Uhlmann M, Weiss A, Federlin K, Geisen K, Brownlee M: Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats. Diabetologia 1995;38:269-273.
7. Hammes HP, Bartmann A, Engel L, Wulfroth P: Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia 1997;40:629-634. (Pubitemid 27288106)
8. Kowluru RA, Tang J, Kern TS: Abnormalities of retinal metabolism in diabetes and experimental galactosemia. Vii. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001;50:1938-1942. (Pubitemid 33641616)
9. Millen AE, Klein R, Folsom AR, Stevens J, Palta M, Mares JA: Relation between intake of vitamins c and e and risk of diabetic retinopathy in the atherosclerosis risk in communities study. Am J Clin Nutr 2004;79:865-873. (Pubitemid 41103889)
10. Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR: The age inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002;51:2826-2832. (Pubitemid 34970937)
11. Boldyrev A, Bulygina E, Leinsoo T, Petrushanko I, Tsubone S, Abe H: Protection of neuronal cells against reactive oxygen species by carnosine and related compounds. Comp Biochem Physiol B Biochem Mol Biol 2004;137:81-88. (Pubitemid 38032888)
12. Hipkiss AR, Brownson C, Bertani MF, Ruiz E, Ferro A: Reaction of carnosine with aged proteins: Another protective process? Ann N Y Acad Sci 2002;959:285-294. (Pubitemid 34457569)
13. Teufel M, Saudek V, Ledig JP, Bernhardt A, Boularand S, Carreau A, Cairns NJ, Carter C, Cowley DJ, Duverger D, Ganzhorn AJ, Guenet C, Heintzelmann B, Laucher V, Sauvage C, Smirnova T: Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 2003;278:6521-6531. (Pubitemid 36800914)
14. Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer E, Baelde H, Bakker SJ, Zirie M, Rondeau E, Mathieson P, Saleem MA, Meyer J, Koppel H, Sauerhoefer S, Bartram CR, Nawroth P, Hammes HP, Yard BA, Zschocke J, van der Woude FJ: Carnosine as a protective factor in diabetic nephropathy: Association with a leucine repeat of the carnosinase gene cndp1. Diabetes 2005;54:2320-2327. (Pubitemid 41134258)
15. Lee YT, Hsu CC, Lin MH, Liu KS, Yin MC: Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol 2005;513:145-150.
16. Jia H, Qi X, Fang S, Jin Y, Han X, Wang Y, Wang A, Zhou H: Carnosine inhibits high glucose-induced mesangial cell proliferation through mediating cell cycle progression. Regul Pept 2009;154:69-76.
17. Sauerhofer S, Yuan G, Braun GS, Deinzer M, Neumaier M, Gretz N, Floege J, Kriz W, van der Woude F, Moeller MJ: L-carnosine, a substrate of carnosinase-1, influences glucose metabolism. Diabetes 2007;56:2425-2432. (Pubitemid 47523249)
18. Kamei J, Ohsawa M, Miyata S, Tanaka S: Preventive effect of l-carnosine on changes in the thermal nociceptive threshold in streptozotocin-induced diabetic mice. Eur J Pharmacol 2008;600:83-86.
19. Klein R, Lee KE, Knudtson MD, Gangnon RE, Klein BE: Changes in visual impairment prevalence by period of diagnosis of diabetes: The wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 2009;116:1937-1942.
20. Babizhayev MA, Kasus-Jacobi A: State of the art clinical efficacy and safety evaluation of n-acetylcarnosine dipeptide ophthalmic prodrug. Principles for the delivery, self-bioactivation, molecular targets and interaction with a highly evolved histidyl-hydrazide structure in the treatment and therapeutic management of a group of sight-threatening eye diseases. Curr Clin Pharmacol 2009;4:4-37.
21. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-791. (Pubitemid 28399611)
22. Kern TS, Barber AJ: Retinal ganglion cells in diabetes. J Physiol 2008;586:4401-4408.
23. Fleisher-Berkovich S, Abramovitch-Dahan C, Ben-Shabat S, Apte R, Beit-Yannai E: Inhibitory effect of carnosine and n-acetyl carnosine on lps-induced microglial oxidative stress and inflammation. Peptides 2009;30:1306-1312.
24. Kusakari Y, Nishikawa S, Ishiguro S, Tamai M: Histidine-like immunoreactivity in the rat retina. Curr Eye Res 1997;16:600-604.
25. Panzanelli P, Cantino D, Sassoe-Pognetto M: Co-localization of carnosine and glutamate in photoreceptors and bipolar cells of the frog retina. Brain Res 1997;758:143-152. (Pubitemid 27310652)
26. Pognetto MS, Cantino D, Fasolo A: Carnosine-like immunoreactivity is associated with synaptic vesicles in photoreceptors of the frog retina. Brain Res 1992;578:261-268.
27. Pognetto MS, Panzanelli P, Fasolo A, Cantino D: Expression of carnosine-like immunoreactivity during retinal development in the clawed frog (xenopus laevis). Brain Res Dev Brain Res 1992;70:134-138.
28. Boldyrev A, Song R, Lawrence D, Carpenter DO: Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species. Neuroscience 1999;94:571-577. (Pubitemid 29436082)
29. Ohkawara T, Nishihira J, Nagashima R, Takeda H, Asaka M: Polaprezinc protects human colon cells from oxidative injury induced by hydrogen peroxide: Relevant to cytoprotective heat shock proteins. World J Gastroenterol 2006;12:6178-6181. (Pubitemid 44688168)
30. Ohkawara T, Takeda H, Kato K, Miyashita K, Kato M, Iwanaga T, Asaka M: Polaprezinc (n-(3-aminopropionyl)-l-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice. Scand J Gastroenterol 2005;40:1321-1327. (Pubitemid 41658731)
31. Mikami K, Otaka M, Watanabe D, Goto T, Endoh A, Miura K, Ohshima S, Yoneyama K, Sato M, Shibuya T, Segawa D, Kataoka E, Yoshino R, Takeuchi S, Sato W, Odashima M, Watanabe S: Zinc l-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72. J Gastroenterol Hepatol 2006;21:1669-1674. (Pubitemid 44410876)
32. Biro K, Jednakovits A, Kukorelli T, Hegedus E, Koranyi L: Bimoclomol (brlp-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats. Brain Res Bull 1997;44:259-263. (Pubitemid 27413729)
33. Biro K, Palhalmi J, Toth AJ, Kukorelli T, Juhasz G: Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats. Neuroreport 1998;9:2029-2033. (Pubitemid 28300561)
34. Schonherr J: Analysis of products of animal origin in feeds by determination of carnosine and related dipeptides by highperformance liquid chromatography. J Agric Food Chem 2002;50:1945-1950. (Pubitemid 34259993)
35. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M: Overexpression of glyoxalase-i in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998;101:1142-1147. (Pubitemid 28125293)
36. Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H: Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun 1999;258:353-357. (Pubitemid 29287055)
37. Chen BH, Jiang DY, Tang LS: Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes. Life Sci 2006;79:1040-1048.
38. Kowluru RA: Diabetic retinopathy: Mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal 2005;7:1581-1587. (Pubitemid 41767993)
39. Busik JV, Mohr S, Grant MB: Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 2008;57:1952-1965.
40. Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, Suske G, Rabbani N, Thornalley PJ, Sarthy VP, Hammes HP, Brownlee M: High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of msin3a. J Biol Chem 2007;282:31038-31045. (Pubitemid 350035169)
41. Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, Aiello LP, Kern TS, King GL: Activation of pkc-delta and shp-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 2009;15:1298-1306.
42. Hammes HP, Lin J, Wagner P, Feng Y, Vom Hagen F, Krzizok T, Renner O, Breier G, Brownlee M, Deutsch U: Angiopoietin-2 causes pericyte dropout in the normal retina: Evidence for involvement in diabetic retinopathy. Diabetes 2004;53:1104-1110. (Pubitemid 38436625)
43. Pfister F, Feng Y, vom Hagen F, Hoffmann S, Molema G, Hillebrands JL, Shani M, Deutsch U, Hammes HP: Pericyte migration: A novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 2008;57:2495-2502.
44. Pfister F, Wang Y, Schreiter K, vom Hagen F, Altvater K, Hoffmann S, Deutsch U, Hammes HP, Feng Y: Retinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia. Acta Diabetol 2010;47:59-64.
45. Simon MP, Tournaire R, Pouyssegur J: The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a hif binding site located in its first intron and by the central factors gata-2 and ets-1. J Cell Physiol 2008;217:809-818.
46. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y: Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999;274:15732-15739.
47. Tait CR, Jones PF: Angiopoietins in tumours: The angiogenic switch. J Pathol 2004;204:1-10. (Pubitemid 39214476)
48. De Marchis S, Modena C, Peretto P, Migheli A, Margolis FL, Fasolo A: Carnosine-related dipeptides in neurons and glia. Biochemistry (Mosc) 2000;65:824-833.
49. Wang Q, Pfister F, Dorn-Beineke A, vom Hagen F, Lin J, Feng Y, Hammes HP: Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina. Diabetologia 2010;53:1227-1238.
50. Lewis GP, Fisher SK: Up-regulation of glial fibrillary acidic protein in response to retinal injury: Its potential role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol 2003;230:263-290. (Pubitemid 37517867)
51. Jackson MC, Scollard DM, Mack RJ, Lenney JF: Localization of a novel pathway for the liberation of gaba in the human cns. Brain Res Bull 1994;33:379-385.
52. Sjaastad O, Berstad J, Gjesdahl P, Gjessing L: Homocarnosinosis. 2. A familial metabolic disorder associated with spastic paraplegia, progressive mental deficiency, and retinal pigmentation. Acta Neurol Scand 1976;53:275-290.
53. Arden GB: The absence of diabetic retinopathy in patients with retinitis pigmentosa: Implications for pathophysiology and possible treatment. Br J Ophthalmol 2001;85:366-370. (Pubitemid 32250774)
54. Arden GB, Wolf JE, Tsang Y: Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis. Vision Res 1998;38:1723-1729. (Pubitemid 28302165)
55. de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW: Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest Ophthalmol Vis Sci 2006;47:5561-5568. (Pubitemid 46723810)